Interesting STZ Put And Call Options For March 27th

Constellation Brands (STZ) trades at $165.96 and the article analyzes two option strategies: selling a $165 put (bid $4.90) which nets an effective purchase basis of $160.10 and has a 53% chance to expire worthless, yielding 2.97% (21.70% annualized) if it does; and selling a $167.50 covered call (bid $4.70) which would produce a 3.76% total return if called or a 2.83% yield boost (20.69% annualized) with a 52% chance to expire worthless at the March 27 expiration. Implied volatilities are ~29% (put) and 30% (call) versus a trailing 12-month volatility of 28%, metrics Stock Options Channel will track on the contract detail pages.

Analysis

Market structure: Short-dated March 27 option interest (put $165 bid $4.90; call $167.50 bid $4.70) benefits option income sellers and cash-rich buyers willing to be assigned — a 2.8–2.97% one-month yield (20–22% annualized) trades off limited directional conviction (OTM probabilities ~52–53%). Equity holders face capped upside if writing calls; primary corporate fundamentals/market share of STZ are unchanged, so this is a flow-driven microliquidity trade, not a secular shift. Cross-asset impact is marginal: slight gamma-driven equity demand into expiry could modestly compress corporate credit spreads if volatility falls, while FX/commodities impact is negligible.

Risk assessment: Tail risks include a consumer-demand shock (2–5% downside in quarters), commodity/input-cost spikes (aluminum/glass) raising COGS by >100–200 bps, or regulatory excise changes affecting margins — any of which would spike IV >45% and blow up naked sellers. Immediate horizon (days): assignment/roll risk into Mar 27 expiry; short-term (weeks): IV mean-reversion to realized ~28%; long-term (quarters): fundamentals drive direction via volumes/price mix. Hidden dependency: option assignment forces cash deployment at $160.10 and reduces liquidity; brokerage margin and tax lot effects matter.

Trade implications: Tactical: sell-to-open 1–3% notional via Mar27 $165 put (effective buy at $160.10) if comfortable owning shares, target IRR ~21% if expired; hedge by buying $155 put as a 0.8:1 protection if downside >6% is unacceptable. Covered-call: buy STZ at $165.96 and sell Mar27 $167.50 to pocket $4.70, target 3.76% one-month return, roll up/forward if >+4% move. Prefer short verticals (sell $165/$160 put spread) versus naked to cap tail risk; consider 1:1 pair long STZ / short BUD for brewery consolidation exposure differential.

Contrarian angles: The market is complacent — IV (~30%) only slightly above realized (28%), implying sellers are being modestly compensated but not for a shock; the 52–53% OTM odds convey no directional edge. If macro CPI or discretionary prints weaken in 2–6 weeks, IV could gap >+15 pts and make income sells painful; conversely, continued earnings stability would make selling premium repeatable. Actionable thresholds: tighten or close positions if IV >45% or STZ moves below $155 (6.7% drop) or above $175 (assign/roll consideration).

Key Decisions for Investors

• Establish a tactical 1–2% portfolio notional position by selling Mar27 STZ $165 puts (collect $4.90) only if prepared to own at $160.10; hedge with a bought $155 put for protection if downside beyond ~6% is unacceptable; close or roll if IV >45% or STZ < $155.
• Buy STZ shares up to 2% notional and sell Mar27 $167.50 covered calls (collect $4.70) to lock ~3.76% one-month return; roll out/adjust if stock > +4% or IV spikes >10 pts before expiry.
• Prefer risk-defined credit spreads over naked positions: sell Mar27 $165/$160 put spread to limit max loss to ~$0.40 (~$40 per spread) while keeping positive carry; size to 1–3% portfolio risk.
• Deploy a relative-value pair trade: long STZ / short BUD ~1:1 for 60–120 day horizon to capture brand/margin resilience; trim if STZ underperforms by >5% vs BUD or if STZ < $155.